Schapoor Hessam

Dr. Schapoor Hessam

Dermatology, Ruhr University Bochum, Bochum, North Rhine-Westphalia, Germany
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Journal of Dermatological Science
Verified
Journal Article
Closed access
MSMichael Sand
Michael Sand
FBFalk G. Bechara
Falk G. Bechara
TGThilo Gambichler
Thilo Gambichler
DSDaniel Sand
Daniel Sand
MBMichael Bromba
Michael Bromba
Schapoor HessamSchapoor Hessam
Schapoor Hessam

4 October 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Schapoor HessamSchapoor Hessam
Schapoor Hessam
MSM. Sand
M. Sand
Thilo GambichlerThilo Gambichler
Thilo Gambichler
MSM. Skrygan
M. Skrygan
IRI. Rüddel
I. Rüddel
FBFalk G. Bechara
Falk G. Bechara

20 April 2016 in Epigenomics
Verified
Journal Article
Closed access
MSMichael Sand
Michael Sand
FBFalk G Bechara
Falk G Bechara
DSDaniel Sand
Daniel Sand
TGThilo Gambichler
Thilo Gambichler
SHStephan Hahn
Stephan Hahn
Schapoor HessamSchapoor Hessam
Schapoor Hessam
Aim: Circular RNAs (circRNAs), are nonprotein coding RNAs consisting of a circular loop with multiple miRNA, binding sites called miRNA response elements (MREs), functioning as miRNA sponges. This study was performed to identify differentially expressed circRNAs and their MREs in basal cell carcinoma (BCC). Materials & methods: Microarray circRNA expression profiles were acquired from BCC and control followed by qRT-PCR validation. Bioinformatical target prediction revealed multiple MREs. Sequence analysis was performed concerning MRE interaction potential with the BCC miRNome. Results: We identified 23 upregulated and 48 downregulated circRNAs with 354 miRNA response elements capable of sequestering miRNA target sequences of the BCC miRNome. Conclusion: The present study describes a variety of circRNAs that are potentially involved in the molecular pathogenesis of BCC.

1 March 2018 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
Schapoor HessamSchapoor Hessam
Schapoor Hessam
LSLisa Scholl
Lisa Scholl
MSMichael Sand
Michael Sand
LSLutz Schmitz
Lutz Schmitz
SRSarah Reitenbach
Sarah Reitenbach
FBFalk G. Bechara
Falk G. Bechara
Hidradenitis suppurativa (HS) is a chronic skin disease that predominantly affects the skin of the intertriginous area through an inflammatory process and results in recurrent nodules, abscesses, sinuses, fistulas, and scarring.1,2 Because the precise description of HS may provide a challenge, considerable efforts have been made to formulate diagnostic criteria and validate clinical descriptive terms for the lesions occurring in patients with HS.3,4 In addition, an international initiative (HS core outcomes set international collaboration) has started to develop a list of mandatory outcomes that should be measured in clinical trials on the treatment of HS.5 However, the variation in clinical appearance and the variability in response to a wide range of proposed treatments underline the importance of an accurate disease severity assessment tool.1,6

1 November 2016 in Journal of Dermatological Science
Verified
Journal Article
Closed access
Schapoor HessamSchapoor Hessam
Schapoor Hessam
MSMichael Sand
Michael Sand
NMNina Mareike Meier
Nina Mareike Meier
TGThilo Gambichler
Thilo Gambichler
LSLisa Scholl
Lisa Scholl
FBFalk G. Bechara
Falk G. Bechara

1 December 2015 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
Schapoor HessamSchapoor Hessam
Schapoor Hessam
MSMichael Sand
Michael Sand
TGThilo Gambichler
Thilo Gambichler
FBFalk G. Bechara
Falk G. Bechara